← Back
$BBNX All transactions

Beta Bionics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$95K

Shares

5,587

Price

$17

Filed

Aug 20

Insider

Name

Feider Stephen

Title

Chief Financial Officer

CIK

0002048588

Roles

Officer

Transaction Details

Transaction Date

2025-08-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

45,503

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. | The weighted average sale price for the transaction reported was $17.034505 and the range of prices were between $17.00 and $17.095. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

Filing Info

Accession No.

0001415889-25-022539

Form Type

4

Issuer CIK

0001674632

Feider Stephen's History

Date Ticker Type Value
2026-03-02 BBNX $18K
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2026-01-02 BBNX M $102K
2026-01-02 BBNX $591K
2026-01-02 BBNX M $0
2025-12-02 BBNX $42K
2025-10-03 BBNX M $25K
2025-10-03 BBNX $82K

Other Insiders at BBNX (90d)

Insider Bought Sold Last
Hopman Mark
Chief Commercial Officer
$103K 2026-03-04
Mensinger Mike
Chief Product Officer
$13K 2026-03-02
Feider Stephen
Chief Financial Officer
$18K 2026-03-02
Saint Sean
President & CEO
$42K 2026-03-02
Russell Steven Jon
Chief Medical Officer
$43K 2026-03-02